Increased expression and/or activation of H-Ras are often associated with tumor aggressiveness in breast cancer. Previously, we showed that H-Ras, but not N-Ras, induces MCF10A human breast epithelial cell invasion and migration, whereas both H-Ras and N-Ras induce cell proliferation and phenotypic transformation. In an attempt to determine the sequence requirement directing the divergent phenotype induced by H-Ras and N-Ras with a focus on the induction of human breast cell invasion, we investigated the structural and functional relationships between H-Ras and N-Ras using domain-swap and site-directed mutagenesis approaches. Here, we report that the hypervariable region (HVR), consisting of amino acids 166 to 189 in H-Ras, determines the i...
Infection with erbB-2 (E) of Ha-ras (H) oncogene-transfected cells has been previously shown to coop...
Basal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have found that ...
SummaryBasal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have foun...
Increased expression and/or activation of H-Ras are often associated with tumor aggressiveness in br...
Increased expression and/or activation of H-Ras are often associated with tumor aggressiveness in br...
AbstractRas proteins are small GTPases that act as signal transducers between cell surface receptors...
Aberrant activation of Ras has been implicated in aggressiveness of breast cancer. Among Ras isoform...
AbstractRecent studies have demonstrated that introduction of hTERT in combination with SV40 large T...
Ras proteins are small GTPase functioning as molecular switches that, in response to particular extr...
Active Ras proteins contribute to breast carcinogenesis and progression. Here, we provide evidence t...
The mechanistic Target of Rapamycin Complex 2 (mTORC2) is an evolutionarily conserved regulator of a...
Activation of multiple signaling pathways is required to trigger the full spectrum of in vitro and i...
To understand the cellular mechanisms of malignant transformation induced by constitutive activation...
BACKGROUND: Activated forms of Ras are enhanced in both breast cancer as well as the cell lines with...
Ha-Ras and Ki-Ras have different distributions across plasma membrane microdomains. The Ras C-termin...
Infection with erbB-2 (E) of Ha-ras (H) oncogene-transfected cells has been previously shown to coop...
Basal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have found that ...
SummaryBasal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have foun...
Increased expression and/or activation of H-Ras are often associated with tumor aggressiveness in br...
Increased expression and/or activation of H-Ras are often associated with tumor aggressiveness in br...
AbstractRas proteins are small GTPases that act as signal transducers between cell surface receptors...
Aberrant activation of Ras has been implicated in aggressiveness of breast cancer. Among Ras isoform...
AbstractRecent studies have demonstrated that introduction of hTERT in combination with SV40 large T...
Ras proteins are small GTPase functioning as molecular switches that, in response to particular extr...
Active Ras proteins contribute to breast carcinogenesis and progression. Here, we provide evidence t...
The mechanistic Target of Rapamycin Complex 2 (mTORC2) is an evolutionarily conserved regulator of a...
Activation of multiple signaling pathways is required to trigger the full spectrum of in vitro and i...
To understand the cellular mechanisms of malignant transformation induced by constitutive activation...
BACKGROUND: Activated forms of Ras are enhanced in both breast cancer as well as the cell lines with...
Ha-Ras and Ki-Ras have different distributions across plasma membrane microdomains. The Ras C-termin...
Infection with erbB-2 (E) of Ha-ras (H) oncogene-transfected cells has been previously shown to coop...
Basal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have found that ...
SummaryBasal-like breast cancers (BLBCs) are aggressive, and their drivers are unclear. We have foun...